Invest in Livanova (LIVN): track its 7.24% YTD gain, 200‑day SMA at $72.46, and market cap of $4.5 bn – learn how the neuromodulation leader compares to peers.
Mayne Pharma (MYX.AX) sees a 1.61% drop, trading around AUD 2.48 after a 16.95% monthly decline; latest 52‑week high at AUD 6.25 – insights on pricing, market cap and peer performance.
Celldex Therapeutics (CLDX) shares are priced at $29.50, trading down 7% month‑to‑date. Discover its biopharma focus, market cap, and recent price action.